Daniel Offen

14.3k total citations · 4 hit papers
211 papers, 11.5k citations indexed

About

Daniel Offen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Daniel Offen has authored 211 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 86 papers in Cellular and Molecular Neuroscience and 55 papers in Neurology. Recurrent topics in Daniel Offen's work include Nerve injury and regeneration (50 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Neurogenesis and neuroplasticity mechanisms (35 papers). Daniel Offen is often cited by papers focused on Nerve injury and regeneration (50 papers), Parkinson's Disease Mechanisms and Treatments (35 papers) and Neurogenesis and neuroplasticity mechanisms (35 papers). Daniel Offen collaborates with scholars based in Israel, United States and Sweden. Daniel Offen's co-authors include Eldad Melamed, Yossi Gilgun‐Sherki, Yael Barhum, Nirit Lev, Nisim Perets, E. Melamed, Ilan Ziv, Ari Barzilai, Tali Ben‐Zur and Ran Barzilay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Daniel Offen

210 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

2001 695 citations Eldad Melamed, Daniel Offen et al. profile →
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy

2004 513 citations Daniel Offen, Eldad Melamed et al. profile →
Intranasal Delivery of Mesenchymal Stem Cell Derived Exosomes Loaded with Phosphatase and Tensin Homolog siRNA Repairs Complete Spinal Cord Injury

2019 345 citations Nisim Perets, Daniel Offen et al. profile →
Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders

2019 320 citations Nisim Perets, Daniel Offen et al. profile →

Peers

Countries citing papers authored by Daniel Offen

Since Specialization

Citations

This map shows the geographic impact of Daniel Offen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Offen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Offen more than expected).

Fields of papers citing papers by Daniel Offen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Offen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Offen. The network helps show where Daniel Offen may publish in the future.

Co-authorship network of co-authors of Daniel Offen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Offen. A scholar is included among the top collaborators of Daniel Offen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Offen. Daniel Offen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mesenchymal stem cell‐derived exosomes mitigate amyloid β‐induced retinal toxicity: Insights from rat model and cellular studies 2025 ·Journal of Extracellular Biology ·(unknown), (unknown), (unknown), Michal Harel, (unknown), Tali Ben‐Zur, Tamar Ziv, Daniel Offen, Shiri Zayit‐Soudry	2
2	Prediction of synonymous corrections by the BE-FF computational tool expands the targeting scope of base editing 2020 ·Nucleic Acids Research ·(unknown), Shiran Abadi, (unknown), Daniel Offen	13
3	Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia 2020 ·Translational Psychiatry ·(unknown), Nisim Perets, Tamar Sofer, Lior Bikovski, Yona Goldshmit, Angela Ruban, Daniel Offen	48
4	Toll‐like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE ‐induced epilepsy in mice 2017 ·Epilepsia ·(unknown), Felix Benninger, Ravit Madar, Tomer Illouz, Kathleen J. Griffioen, Israel Steiner, Daniel Offen, Eitan Okun	49
5	Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism 2017 ·Behavioural Brain Research ·Nisim Perets, (unknown), Yaël Gothelf, Ran Barzilay, Yael Barhum, Natalie Abramov, (unknown), Darya Morozov, Michael London, Daniel Offen	42
6	The Role of Toll-Like Receptor 3 in Epileptogenesis (I1-2.001) 2014 ·Neurology ·Felix Benninger, (unknown), Israel Steiner, Daniel Offen, Eitan Okun	1
7	Dopaminergic-Like Neurons Derived from Oral Mucosa Stem Cells by Developmental Cues Improve Symptoms in the Hemi-Parkinsonian Rat Model 2014 ·PLoS ONE ·Javier Ganz, (unknown), (unknown), (unknown), Yael Barhum, (unknown), (unknown), S. Pitaru, Daniel Offen	17
8	Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease 2012 ·Experimental Neurology ·Ofer Sadan, Noam Shemesh, Ran Barzilay, (unknown), Tamar Blumenfeld‐Katzir, Yaniv Assaf, Moshe Yeshurun, Ruth Djaldetti, Yoram Cohen, E. Melamed, Daniel Offen	62
9	Differentiated Mesenchymal Stem Cells for Sciatic Nerve Injury 2011 ·Stem Cell Reviews and Reports ·(unknown), Ofer Sadan, (unknown), Eldad Melamed, Daniel Offen	54
10	The “Dying-Back” Phenomenon of Motor Neurons in ALS 2010 ·Journal of Molecular Neuroscience ·(unknown), Eldad Melamed, Daniel Offen	291
11	Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains 2009 ·Cytotherapy ·Ran Barzilay, Ofer Sadan, Eldad Melamed, Daniel Offen	30
12	Lentiviral Delivery of LMX1a Enhances Dopaminergic Phenotype in Differentiated Human Bone Marrow Mesenchymal Stem Cells 2008 ·Stem Cells and Development ·Ran Barzilay, Tali Ben‐Zur, Shlomo Bulvik, Eldad Melamed, Daniel Offen	46
13	Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition 2006 ·Stem Cells and Development ·(unknown), Yossef S. Levy, Tali Ben‐Zur, (unknown), (unknown), (unknown), (unknown), (unknown), Yael Barhum, Shlomo Bulvik, Eldad Melamed, Daniel Offen	135
14	Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model 2006 ·Experimental Neurology ·(unknown), Yael Barhum, (unknown), (unknown), Eldad Melamed, Daniel Offen	35
15	Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease 2001 ·Neuroscience Letters ·Daniel Offen, Biana Shtaif, (unknown), Abraham Weizman, Eldad Melamed, Irit Gil‐Ad	94
16	Mice Overexpressing Bcl-2 in Their Neurons Are Resistant to Myelin Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis (EAE) 2000 ·Journal of Molecular Neuroscience ·Daniel Offen, (unknown), Ora Bernard, Doron Merims, (unknown), Hana Panet, Eldad Melamed, Avraham Ben‐Nun	24
17	The Involvement of p53 in Dopamine-Induced Apoptosis of Cerebellar Granule Neurons and Leukemic Cells Overexpressing p53 1999 ·Cellular and Molecular Neurobiology ·(unknown), Ari Barzilai, Daniel Offen, Ariel Kamsler, Eldad Melamed, (unknown)	42
18	Levodopa Toxicity and Apoptosis 1998 ·Annals of Neurology ·(unknown), Daniel Offen, Anat Shirvan, Ruth Djaldetti, Ari Barzilai, Ilan Ziv	66
19	Levodopa induces apoptosis in cultured neuronal cells—A possible accelerator of nigrostriatal degeneration in Parkinson's disease? 1997 ·Movement Disorders ·Ilan Ziv, Rina Zilkha‐Falb, Daniel Offen, Anat Shirvan, Ari Barzilai, Eldad Melamed	79
20	The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's Disease 1997 ·APOPTOSIS ·I. Ziv, Daniel Offen, (unknown), Reuven Stein, Hana Panet, Rina Zilkha‐Falb, Anat Shirvan, Ari Barzilai, E. Melamed	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact